EUVIMEDEUVIMED entdecken
Crossref

Vitamin D and Pregnancy Loss: Biological Plausibility, Clinical Evidence and Current Controversies

Dimitra Papakosta, Nikolaos Roussos, Tilemachos Karalis, Panagiotis Tsavalos, Grigorios F. Grimbizis, Angelos Daniilidis

Hellenic Journal of Obstetrics and Gynecology · 30.10.2026 · 25 (4) · 335-345

DOI: 10.33574/hjog.0640 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hellenic Journal of Obstetrics and Gynecology, online erschienen am 30.10.2026. Verfasst von Dimitra Papakosta und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vitamin D, beyond its classical role in calcium homeostasis and bone metabolism, exerts immunomodulatory and paracrine effects in reproductive tissues. Emerging evidence suggests a potential link between maternal vitamin D deficiency and miscarriage, particularly recurrent pregnancy loss (RPL). This review critically evaluates the biological plausibility and clinical evidence underlying this association. Material and Methods: A structured literature search was performed in PubMed/MEDLINE, Embase, and Cochrane Library up to March 2026 using terms related to vitamin D and miscarriage. Eligible studies included human observational studies, interventional trials, and Mendelian randomization (MR) analyses assessing maternal 25-hydroxyvitamin D (25(OH)D) levels or supplementation in relation to miscarriage or RPL. Data extracted encompassed study design, population, vitamin D assessment, intervention, and pregnancy outcomes. Ten primary studies were included in the review, along with relevant meta-analyses and systematic reviews.

Results

Observational studies consistently report that low maternal 25(OH)D levels are associated with an increased risk of first-trimester miscarriage and RPL. Meta-analyses and umbrella reviews confirm these associations but highlight significant heterogeneity. MR studies do not support a direct causal effect of low vitamin D on miscarriage risk, suggesting that deficiency may be a marker of other risk factors (38). Interventional trials in high-risk women demonstrate that vitamin D supplementation improves immunologic profiles (Treg/Th17 balance, IL-23, IFN-γ) and may reduce miscarriage rates. Mechanistic studies reveal that vitamin D influences trophoblast function, endometrial receptivity, and maternal immune tolerance via the VDR/CYP27B1 pathway and HOXA10 expression.

Conclusions

Vitamin D deficiency is prevalent among women experiencing miscarriage, particularly in early pregnancy and RPL. Evidence supports a biologically plausible immunomodulatory mechanism. While supplementation shows potential benefit in high-risk populations, routine vitamin D supplementation for miscarriage prevention cannot yet be universally recommended. Future large-scale, well-powered clinical trials are warranted to define optimal dosing, timing, and target populations.

Zitieren

APA

Papakosta, D., Roussos, N., Karalis, T., Tsavalos, P., Grimbizis, G. F., & Daniilidis, A. (2026). Vitamin D and Pregnancy Loss: Biological Plausibility, Clinical Evidence and Current Controversies. Hellenic Journal of Obstetrics and Gynecology, 25(4), 335-345. https://doi.org/10.33574/hjog.0640

Vancouver

Papakosta D, Roussos N, Karalis T, Tsavalos P, Grimbizis GF, Daniilidis A. Vitamin D and Pregnancy Loss: Biological Plausibility, Clinical Evidence and Current Controversies. Hellenic Journal of Obstetrics and Gynecology. 2026;25(4):335-345. doi:10.33574/hjog.0640

BibTeX
@article{Papakosta2026,
  author = {Papakosta, Dimitra and Roussos, Nikolaos and Karalis, Tilemachos and Tsavalos, Panagiotis and Grimbizis, Grigorios F. and Daniilidis, Angelos},
  title = {Vitamin D and Pregnancy Loss: Biological Plausibility, Clinical Evidence and Current Controversies},
  journal = {Hellenic Journal of Obstetrics and Gynecology},
  year = {2026},
  volume = {25},
  number = {4},
  pages = {335--345},
  doi = {10.33574/hjog.0640}
}
Kostenlos starten →